BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8621777)

  • 1. Stromelysin-3 expression promotes tumor take in nude mice.
    Nöel AC; Lefebvre O; Maquoi E; VanHoorde L; Chenard MP; Mareel M; Foidart JM; Basset P; Rio MC
    J Clin Invest; 1996 Apr; 97(8):1924-30. PubMed ID: 8621777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration in vivo that stromelysin-3 functions through its proteolytic activity.
    Noël A; Boulay A; Kebers F; Kannan R; Hajitou A; Calberg-Bacq CM; Basset P; Rio MC; Foidart JM
    Oncogene; 2000 Mar; 19(12):1605-12. PubMed ID: 10734321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front.
    Andarawewa KL; Motrescu ER; Chenard MP; Gansmuller A; Stoll I; Tomasetto C; Rio MC
    Cancer Res; 2005 Dec; 65(23):10862-71. PubMed ID: 16322233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression.
    Andarawewa KL; Boulay A; Masson R; Mathelin C; Stoll I; Tomasetto C; Chenard MP; Gintz M; Bellocq JP; Rio MC
    Cancer Res; 2003 Sep; 63(18):5844-9. PubMed ID: 14522908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors.
    Kawami H; Yoshida K; Ohsaki A; Kuroi K; Nishiyama M; Toge T
    Anticancer Res; 1993; 13(6A):2319-23. PubMed ID: 8297152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
    Muller D; Wolf C; Abecassis J; Millon R; Engelmann A; Bronner G; Rouyer N; Rio MC; Eber M; Methlin G
    Cancer Res; 1993 Jan; 53(1):165-9. PubMed ID: 7677979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromelysin-3 gene expression in human cancer: an overview.
    Rouyer N; Wolf C; Chenard MP; Rio MC; Chambon P; Bellocq JP; Basset P
    Invasion Metastasis; 1994-1995; 14(1-6):269-75. PubMed ID: 7657519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
    Wang F; Tian YH; Li L; Chen XF; Hu HH; Li CY; Huang Q
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):165-70. PubMed ID: 12006990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase.
    Boulay A; Masson R; Chenard MP; El Fahime M; Cassard L; Bellocq JP; Sautès-Fridman C; Basset P; Rio MC
    Cancer Res; 2001 Mar; 61(5):2189-93. PubMed ID: 11280785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense construct.
    Perlaky L; Valdez BC; Busch RK; Larson RG; Jhiang SM; Zhang WW; Brattain M; Busch H
    Cancer Res; 1992 Jan; 52(2):428-36. PubMed ID: 1728415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
    J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
    Chang JY; Xia W; Shao R; Sorgi F; Hortobagyi GN; Huang L; Hung MC
    Oncogene; 1997 Feb; 14(5):561-8. PubMed ID: 9053854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
    Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
    Pötgens AJ; van Altena MC; Lubsen NH; Ruiter DJ; de Waal RM
    Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
    Ahmad A; Hanby A; Dublin E; Poulsom R; Smith P; Barnes D; Rubens R; Anglard P; Hart I
    Am J Pathol; 1998 Mar; 152(3):721-8. PubMed ID: 9502414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
    Nakashiro K; Kawamata H; Hino S; Uchida D; Miwa Y; Hamano H; Omotehara F; Yoshida H; Sato M
    Cancer Res; 1998 Feb; 58(3):549-55. PubMed ID: 9458104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
    Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
    BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
    Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix-degrading metalloproteinases in tumor progression.
    Matrisian LM; Wright J; Newell K; Witty JP
    Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.